Latest biopharmaceutical Stories
Freeslate System Supports the Exploration of Broader Formulation Experimental Space with a Reduced Material Requirement SUNNYVALE, Calif. (PRWEB) September 03, 2013 Freeslate, Inc., the leading provider of high throughput research solutions, today announced that KBI Biopharma, Inc. (KBI), a leading development and contract manufacturing organization serving the biopharmaceutical industry, has purchased Freeslate’s Biologics Formulation System to help develop more robust formulations...
- The offense of persistently instigating lawsuits, typically groundless ones.
- An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
- Sale or purchase of positions in church or state.